Biofrontera Inc. – NASDAQ:BFRI
Biofrontera stock price today
$0.93
-0.18
-16.22%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 12 hours
Biofrontera stock price monthly change
+4.72%
month
Biofrontera stock price quarterly change
+4.72%
quarter
Biofrontera stock price yearly change
-60.64%
year
Biofrontera key metrics
Market Cap | 7.78M |
Enterprise value | N/A |
P/E | -20 |
EV/Sales | -0.11 |
EV/EBITDA | -3.40 |
Price/Sales | 0.44 |
Price/Book | 0.53 |
PEG ratio | -0.20 |
EPS | -13.1 |
Revenue | 33.22M |
EBITDA | -21.88M |
Income | -23.09M |
Revenue Q/Q | -9.52% |
Revenue Y/Y | 20.13% |
Profit margin | -2.23% |
Oper. margin | -78.05% |
Gross margin | 47.04% |
EBIT margin | -78.05% |
EBITDA margin | -65.88% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBiofrontera stock price history
Biofrontera stock forecast
Biofrontera financial statements
| Jun 2023 | 5.84M | -9.83M | -168.21% |
|---|---|---|---|
| Sep 2023 | 8.87M | -6.34M | -71.43% |
| Dec 2023 | 10.59M | 3.52M | 33.28% |
| Mar 2024 | 7.90M | -10.43M | -132.1% |
| Mar 2024 | 7.90M | -10.43M | -132.1% |
|---|---|---|---|
| Sep 2025 | 9.2M | -1.22M | -13.26% |
| Oct 2025 | 8.6M | -543.53K | -6.32% |
| Dec 2025 | 16.3M | 289.88K | 1.78% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 36905000 | 29.73M | 80.56% |
|---|---|---|---|
| Sep 2023 | 34104000 | 33.06M | 96.96% |
| Dec 2023 | 27932000 | 23.13M | 82.84% |
| Mar 2024 | 24575000 | 29.99M | 122.04% |
| Jun 2023 | -10.33M | 178K | 1.10M |
|---|---|---|---|
| Sep 2023 | -2.00M | 382K | 591K |
| Dec 2023 | -8.86M | 73K | 6.71M |
| Mar 2024 | -3.32M | 0 | 5.79M |
Biofrontera alternative data
| Aug 2023 | 81 |
|---|---|
| Sep 2023 | 81 |
| Oct 2023 | 81 |
| Nov 2023 | 81 |
| Dec 2023 | 81 |
| Jan 2024 | 81 |
| Feb 2024 | 81 |
| Apr 2024 | 83 |
| May 2024 | 83 |
| Jun 2024 | 83 |
| Jul 2024 | 83 |
Biofrontera other data
1.82%
-1.68%
of BFRI is owned by hedge funds
414.43K
-381.13K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|
| Quarter | Transcript |
|---|---|
| Q1 2024 16 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 18 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 10 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 11 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Ms. Erica L. Monaco CPA (1985) Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Treasurer & Sec. | $311,460 |
-
What's the price of Biofrontera stock today?
One share of Biofrontera stock can currently be purchased for approximately $0.93.
-
When is Biofrontera's next earnings date?
Unfortunately, Biofrontera's (BFRI) next earnings date is currently unknown.
-
Does Biofrontera pay dividends?
No, Biofrontera does not pay dividends.
-
How much money does Biofrontera make?
Biofrontera has a market capitalization of 7.78M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18.82% to 34.07M US dollars.
-
What is Biofrontera's stock symbol?
Biofrontera Inc. is traded on the NASDAQ under the ticker symbol "BFRI".
-
What is Biofrontera's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Biofrontera?
Shares of Biofrontera can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Biofrontera's key executives?
Biofrontera's management team includes the following people:
- Ms. Erica L. Monaco CPA Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Treasurer & Sec.(age: 40, pay: $311,460)
-
How many employees does Biofrontera have?
As Jul 2024, Biofrontera employs 83 workers.
-
When Biofrontera went public?
Biofrontera Inc. is publicly traded company for more then 3 years since IPO on 29 Oct 2021.
-
What is Biofrontera's official website?
The official website for Biofrontera is biofrontera.us.com.
-
Where are Biofrontera's headquarters?
Biofrontera is headquartered at 120 Presidential Way, Woburn, MA.
-
How can i contact Biofrontera?
Biofrontera's mailing address is 120 Presidential Way, Woburn, MA and company can be reached via phone at +7 812451325.
Biofrontera company profile:
Biofrontera Inc.
biofrontera.us.comExchange:
NASDAQ
Full time employees:
83
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
120 Presidential Way
Woburn, MA 01801
Woburn, MA 01801
CIK: 0001858685
ISIN: US09077D2099
CUSIP: 09077D100
